The exact math on 2026's most dramatic large-cap comeback -- and the question it leaves for latecomers.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
NVIDIA (NasdaqGS:NVDA) announced a new collaboration with Verkada to accelerate physical AI adoption in real world environments. NVIDIA will become a strategic investor in Verkada and work on AI search and safety applications for buildings and other physical spaces. The company also appointed former Microsoft executive Nicholas Parker as EVP, Worldwide Field Operations, signaling a change in its go to market leadership. NVIDIA enters this news cycle with its stock at $194.83 and very large...
Nvidia could have a monster second half of 2026.
Consider the potential risk and reward of SpaceX stock heading into earnings season.
Anthropic will likely start trading in the coming months.
AMD has delivered impressive gains to investors in 2026, but its momentum has weakened over the past month.
Memory companies are poised to grow impressively due to artificial intelligence (AI)-fueled demand, and this fund helps them capitalize on this rapidly growing market.
Many investors are still heavily invested in the S&P 500 and tech stocks. It's time to begin looking beyond these two options.
The market applauded Rocket Lab's potential expansion into the satellite business, reinforcing the company's ambitions for growth in space applications.
Most investors are unaware of this stock, which is up 30% year to date.
Micron stock has more than tripled so far in 2026, and recently became a member of the trillion-dollar club.
SpaceX has been a rocket, but rockets can explode.
The life insurance business model will be a big winner if rates stay high or rise even further.
The REX FANG & Innovation Equity Premium Income ETF (NASDAQ:FEPI) is one of the most aggressive volatility-income products on the market, selling calls against a concentrated basket of AI and mega-cap tech names to fund weekly cash distributions. Recent payouts have run roughly $0.21 per week against a share price of about $42, which annualizes ... FEPI’s 25% Yield Masks a Painful Truth About Call-Writing Income
The maker of small modular reactors deserves some more attention.
Despite a fantastic 711% trailing-10-year return, Netflix shares are currently 45% off their peak.
The upside and risks associated with ASML are more important to long-term shareholders than a stock split.
Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two different playbooks for winning in healthcare. Lilly is riding a GLP-1 wave. JNJ is proving that a wide, refreshed portfolio can still compound. Both raised guidance and both are worth putting side by side right now. GLP-1 Fireworks ... Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly
This under-the-radar company doesn't get the recognition that semiconductor specialists receive -- but it certainly should.
Rocket Lab's bold takeover of Iridium could help it keep up with SpaceX.
The slump in oil prices has made this oil stock a no-brainer buy right now.
Procter & Gamble (NYSE:PG) and Colgate-Palmolive (NYSE:CL) both posted top and bottom line beats in their most recent quarters. PG’s fiscal Q3 2026 leaned on Beauty and broad regional strength. Colgate’s Q1 2026 leaned on Latin America and Hill’s Pet. Same shelf, very different engines. Beauty Powers P&G. Latin America Powers Colgate. P&G’s headline was ... Procter & Gamble vs Colgate-Palmolive: Two Consumer Giants, Two Strategies, One Invests, Other Optimizes
I want to AI-proof my finances.
Should investors fear the gold stock's recent decline or buy the dip?
The AI infrastructure company still has a bright future.
SpaceX stock is 19% off its peak.
The massive spending by hyperscalers is creating massive demand for reliable energy solutions.
Arm Holdings (NASDAQ:ARM) has been one of 2026’s most dramatic stories, ripping from a January low near $105 to a record $452.70 in June before giving back gains. With shares now near $315, the question is whether the AI CPU thesis still has room to run or if the easy money has already been made. ... Why Arm Is a Strong Buy Despite the 35% Pullback From Peak Levels
These companies each get a lot of attention, but for completely different reasons.